You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis b Virus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

Not yet recruiting
  • Cutaneous Warts
  • Hepatitis B Virus Vaccine(HBV)
  • (no location specified)
Jun 13, 2023

Hepatitis B Virus Reactivation:Cautionary Event After Liver

Completed
  • Liver Transplant; Complications
  • Diagnosis of postoperative recurrence of liver cancer
  • (no location specified)
Oct 27, 2023

Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)

Not yet recruiting
  • Chronic Hepatitis b
  • Rotterdam, Netherlands
    Erasmus MC
Apr 21, 2023

IBD Trial (standard hepatitis B vaccine, accelerated HBV Vaccine)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • standard hepatitis B vaccine
  • accelerated HBV Vaccine
  • (no location specified)
Jul 27, 2023

Hepatic Steatosis and Chronic Hepatitis B Virus

Not yet recruiting
  • Chronic Hepatitis
  • Liver biopsy
  • Sohag, Egypt
    Faculty of medicine
Dec 28, 2022

Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

Not yet recruiting
  • Chronic Hepatitis B
  • (no location specified)
Feb 28, 2023

Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

Not yet recruiting
  • Chronic Hepatitis b
  • +2 more
  • Anti-PD-1 antibody
  • +2 more
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023

Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
  • (no location specified)
Jun 12, 2023

Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

Not yet recruiting
  • Chronic Hepatitis b
  • Anti-PD-1 Antibody
  • Anti-PD-1 antibody
  • NAs
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 3, 2023

Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent Trial in New York, Hong Kong, Singapore

Recruiting
  • Hepatitis B Virus Related Hepatocellular Carcinoma
  • Hepatocellular Carcinoma Recurrent
  • SCG101
  • New York, New York
  • +4 more
Nov 18, 2022

Cell-free DNA From Junction of Hepatitis B Virus Integration in

Active, not recruiting
  • Hepatocellular Carcinoma
    • Taipei, Taiwan
      National Taiwan University Hospital
    Apr 10, 2023

    Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

    Recruiting
    • Lung Transplant
    • Hepatitis B
    • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
    • Philadelphia, Pennsylvania
      Hospital of University of Pennsylvania
    Oct 1, 2022

    Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

    Terminated
    • Hepatitis B, Chronic
    • Hepatitis D
    • Chisinau, Republic Of Moldova, Moldova, Republic of
    • +1 more
    Nov 15, 2022

    Hepatitis B, Portal Hypertension Trial (Atorvastatin 10mg, Placebo)

    Not yet recruiting
    • Hepatitis B
    • Portal Hypertension
    • Atorvastatin 10mg
    • Placebo
    • (no location specified)
    Jul 29, 2022

    Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn Trial in Chongqing

    Recruiting
    • Vaccination Reaction
    • +4 more
      • Chongqing, Chongqing, China
        Children's Hospital of Chongqing Medical University
      Sep 7, 2023

      Chronic Hepatitis b Trial in Lyon (procedure, biological, other)

      Not yet recruiting
      • Chronic Hepatitis b
      • Investigation of the intrahepatic compartment using the fine needle aspiration (FNA) technique
      • +2 more
      • Lyon, France
        Hepatology Department - Hospices Civils de Lyon
      Sep 14, 2023

      Chronic Hepatitis B Trial in Beijing (TCR-T)

      Active, not recruiting
      • Chronic Hepatitis B
      • TCR-T
      • Beijing, China
        The Fifth Medical Center of PLA General Hospital
      Jun 13, 2023

      Chronic Hepatitis B Virus Infection in Zambia

      Active, not recruiting
      • HBV
      • +5 more
      • Standard of care
      • Lusaka, Zambia
        Tropical Gastroenterology and Nutrition Group
      Jun 1, 2022

      Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

      Not yet recruiting
      • Hepatitis b Virus
      • HepB mAb19
      • Sterile Saline
      • New York, New York
      • +1 more
      May 12, 2023

      Hepatitis B Virus Related Hepatocellular Carcinoma Trial (The Simply B Study)

      Not yet recruiting
      • Hepatitis B Virus Related Hepatocellular Carcinoma
      • The Simply B Study
      • (no location specified)
      Nov 7, 2022

      TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High

      Recruiting
      • Chronic Hepatitis b
      • Pregnancy Related
        • Guangzhou, Guangdong, China
          The Third Affiliated Hospital, Guangzhou Medical University
        Jul 18, 2022

        Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis

        Recruiting
        • Chronic Hepatitis b
        • test of HBV DNA
        • Xi'an, Shaanxi, China
          First Affiliated Hospital of Xi'an JiaotongUniversity
        Mar 28, 2022

        Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

        Active, not recruiting
        • Hepatitis B, Chronic
        • Edegem, Belgium
        • +12 more
        Jan 17, 2023

        Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

        Active, not recruiting
        • Hepatitis B
        • Baltimore, Maryland
        • +9 more
        Jan 17, 2023

        Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial

        Not yet recruiting
        • Hepatocellular Carcinoma
        • +3 more
          • (no location specified)
          Feb 21, 2023